Salesforce (CRM, $228.67) to reopen San Francisco office in May
Salesforce.com announced that it is planning to reopen its San Francisco headquarters in May along with its offices in Palo Alto and Irvine, Calif.
The cloud company’s tower in San Francisco has 61 floors and 1.4 million square feet of office space. Office attendance will not be compulsory in the beginning, as employees will have the option to work from home through year's end.
Office reopening will occur in three stages. In the first stage, which is limited to the U.S. and only in areas that have a company-assigned coronavirus risk rating that’s flat or decreasing, fully vaccinated employees can volunteer to join groups of up to 100 people who can work on certain floors; the company will require employees to take Covid tests twice a week. In the second stage, Salesforce will operate at 20% to 75% capacity based on the company’s assessment of risk, and employees can enter office even if they have not received a vaccine. The final stage will allow offices to operate up to 100% capacity.
According to the company, it has already safely opened 22 offices globally, for business-critical employees (who have been at different offices since the beginning of the pandemic). Most of those 22 offices reopened last May in China, South Korea, and Hong Kong.
In a separate statement, Salesforce said it was donating $1.5 million to fight homelessness.
CRM sees its Stochastic Oscillator climbs out of oversold territory
On October 25, 2024, the Stochastic Oscillator for CRM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 25, 2024. You may want to consider a long position or call options on CRM as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 293 cases where CRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CRM moved out of overbought territory on October 11, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for CRM turned negative on October 21, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.916) is normal, around the industry mean (30.698). P/E Ratio (71.967) is within average values for comparable stocks, (161.895). Projected Growth (PEG Ratio) (1.620) is also within normal values, averaging (2.738). Dividend Yield (0.001) settles around the average of (0.083) among similar stocks. P/S Ratio (8.532) is also within normal values, averaging (55.771).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a developer of on-demand customer relationship management software technology
Industry PackagedSoftware